| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/03602530600569919 |
| P698 | PubMed publication ID | 16684653 |
| P2093 | author name string | David E Williams | |
| Sharon K Krueger | |||
| Ronald N Hines | |||
| Jonathan E Vandyke | |||
| P2860 | cites work | The flavin-containing monooxygenase 2 gene (FMO2) of humans, but not of other primates, encodes a truncated, nonfunctional protein | Q22004271 |
| Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism | Q22251223 | ||
| Human flavin-containing monooxygenase form 2 S-oxygenation: sulfenic acid formation from thioureas and oxidation of glutathione | Q24293146 | ||
| Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics | Q24539077 | ||
| Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6) | Q28182512 | ||
| Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans | Q28203039 | ||
| Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression | Q28216584 | ||
| Stereoselective metabolism of (S)-(-)-nicotine in humans: formation of trans-(S)-(-)-nicotine N-1'-oxide | Q28250108 | ||
| The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression | Q28250605 | ||
| The molecular biology of the flavin-containing monooxygenases of man | Q28300051 | ||
| Phenotypes of flavin-containing monooxygenase activity determined by ranitidine N-oxidation are positively correlated with genotypes of linked FM03 gene mutations in a Korean population | Q28374623 | ||
| Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers | Q28573539 | ||
| Alpha-hydroxylation of tamoxifen and toremifene by human and rat cytochrome P450 3A subfamily enzymes | Q28576392 | ||
| Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA. | Q33389761 | ||
| The tamoxifen dilemma | Q33671066 | ||
| Trimethylaminuria and a human FMO3 mutation database | Q34225073 | ||
| Study on the organoleptic intensity scale for measuring oral malodor. | Q34285698 | ||
| Structural and catalytic properties of the mammalian flavin-containing monooxygenase | Q34311922 | ||
| Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6. | Q34322613 | ||
| The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes | Q34502898 | ||
| Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism | Q34673357 | ||
| An overview of the mechanism, substrate specificities, and structure of FMOs | Q34818980 | ||
| Genetic polymorphisms of flavin-containing monooxygenase (FMO). | Q34819029 | ||
| Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation | Q34849013 | ||
| Flavin-containing monooxygenases: catalytic mechanism and substrate specificities | Q39654203 | ||
| Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen. | Q40463031 | ||
| CYP2D6-mediated catalysis of tamoxifen aromatic hydroxylation with an NIH shift: similar hydroxylation mechanism in chicken, rat and human liver microsomes | Q44353593 | ||
| Evaluation of xenobiotic N- and S-oxidation by variant flavin-containing monooxygenase 1 (FMO1) enzymes | Q44771795 | ||
| Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. | Q44836596 | ||
| Flavin-containing monooxygenase isoform specificity for the N-oxidation of tamoxifen determined by product measurement and NADPH oxidation | Q44872457 | ||
| Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent | Q45050361 | ||
| Genetic polymorphisms of human flavin monooxygenase 3 in sulindac-mediated primary chemoprevention of familial adenomatous polyposis | Q45205080 | ||
| Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment | Q46520781 | ||
| Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin | Q46575106 | ||
| Involvement of cytochrome P4503A in catalysis of tamoxifen activation and covalent binding to rat and human liver microsomes. | Q53468349 | ||
| A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes. | Q53473144 | ||
| Hepatic microsomal mixed-function amine oxidase | Q67358280 | ||
| Microsomal oxidase. IV. Properties of a mixed-function amine oxidase isolated from pig liver microsomes | Q70378536 | ||
| Tamoxifen metabolism by microsomal cytochrome P450 and flavin-containing monooxygenase | Q71497736 | ||
| Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3 | Q77425114 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tamoxifen | Q412178 |
| P304 | page(s) | 139-147 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Drug Metabolism Reviews | Q5308857 |
| P1476 | title | The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines | |
| P478 | volume | 38 |
| Q92229907 | Ancestral-sequence reconstruction unveils the structural basis of function in mammalian FMOs |
| Q45218281 | Development of a CD-MEKC method for investigating the metabolism of tamoxifen by flavin-containing monooxygenases and the inhibitory effects of methimazole, nicotine and DMXAA. |
| Q51770720 | Dietary trans 10, cis 12-conjugated linoleic acid reduces the expression of fatty acid oxidation and drug detoxification enzymes in mouse liver. |
| Q45050255 | Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation |
| Q37008890 | Flavin-containing monooxygenase 3 and human disease |
| Q55359029 | In silico prediction of potential chemical reactions mediated by human enzymes. |
| Q34038020 | Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness |
| Q90525391 | Production of drug metabolites by human FMO3 in Escherichia coli |
| Q46639348 | Role of the Red Ginseng in Defense against the Environmental Heat Stress in Sprague Dawley Rats. |
| Q36140832 | SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma |
| Q37772507 | The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism |
| Q36107130 | Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide |
| Q47155427 | Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer |
Search more.